Skip to main content
Everlywell

Everlywell

Direct-to-consumer health testing company offering at-home lab tests for wellness, reproductive health, and general health monitoring.

Digital HealthAustin, TexasFounded 2015Website →

About Everlywell

Everlywell provides direct-to-consumer health testing services through at-home lab test kits. The company offers tests for food sensitivities, hormone levels, STDs, vitamin deficiencies, and other health markers that customers can complete at home and receive results through a digital platform. Everlywell aims to make health testing more accessible and convenient, partnering with certified labs and healthcare providers to deliver actionable health insights.

Investors & Backers

Everlywell has received investment from 1 venture capital firm.

Frequently Asked Questions

What does Everlywell do?

Direct-to-consumer health testing company offering at-home lab tests for wellness, reproductive health, and general health monitoring.

Who invested in Everlywell?

Everlywell has received investment from Behind Genius Ventures. These venture capital firms and investors provide both capital and strategic support.

How much funding has Everlywell raised?

Everlywell has raised $350M in total funding, with their most recent round being a Series C. The company operates in the Digital Health sector.

When was Everlywell founded?

Everlywell was founded in 2015 and is headquartered in Austin, Texas.

What sector is Everlywell in?

Everlywell operates in the Digital Health sector. Direct-to-consumer health testing company offering at-home lab tests for wellness, reproductive health, and general health monitoring.

Sponsored
AArchstone

The operating system for private capital.

Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.

LP portalCapital calls$297/moNo AUM fees
Book a demo

Company Details

Sector
Digital Health
Headquarters
Austin, Texas
Founded
2015
Status
Active
Last Funding Stage
Series C
Total Funding
$350M
Valuation
$2.9B

Related Digital Health Companies